Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NEFAZODONE vs NEMOLIZUMAB: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NEFAZODONE vs NEMOLIZUMAB: Safety Overview

Metric NEFAZODONE NEMOLIZUMAB
Total FAERS Reports 284 371
Deaths Reported 11 54
Death Rate 3.9% 14.6%
Hospitalizations 37 136
Average Patient Age 56.4 yrs 63.9 yrs
% Female Patients 66.6% 37.5%
FDA Approval Date Dec 22, 1994 N/A
Manufacturer Teva Pharmaceuticals USA, Inc. Galderma Laboratories, L.P.
Route ORAL SUBCUTANEOUS
Marketing Status Discontinued N/A